| Model Number |
A-FASE-F |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Aortic Dissection (2491); Cardiac Perforation (2513)
|
| Date of Event |
09/30/2019
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
The results/method and conclusion codes along with investigation results will be provided in the final report further information regarding the event were requested but not received.
|
| |
|
Event or Problem Description
|
|
During a ventricular tachycardia ablation procedure, an aortic puncture by the transseptal needle resulting in a pericardial effusion occurred.Following mapping of the left ventricle in a retroaortic approach, access to the left ventricle with a transeptal approach was attempted.After the transseptal puncture the patient became hypotensive.An echocardiograph confirmed a pericardial effusion.The pressure did not increase and the patient was brought to surgery, where the aorta was sutured to stabilize the patient.The next day the patient was stable with no visible consequences.There were no performance issues with any abbott device.
|
| |
|
Additional Manufacturer Narrative
|
|
The results of the investigation are inconclusive since the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.Based on the information received, the cause of the reported effusion could not be conclusively determined.Per the ifu, cardiac perforation is a known risk during the use of this device.
|
| |
|
Search Alerts/Recalls
|